polyethylene glycol

(redirected from MoviPrep)
Also found in: Dictionary, Encyclopedia.

polyethylene

 [pol″e-eth´ĭ-lēn]
polymerized ethylene, (—CH2—CH2—)n, a synthetic plastic material, forms of which have been used in reparative surgery.
polyethylene glycol a polymer of ethylene oxide and water, available in liquid form (polyethylene glycol 300 or 400) or as waxy solids (polyethylene glycol 1540 or 4000), used in various pharmaceutical preparations as a water-soluble ointment base. Polyethylene glycol is also used as a laxative.

polyethylene glycol

n.
Any of a family of high molecular weight liquids and waxes that are condensation polymers of ethylene glycol, are soluble in water and in many organic solvents, and are used in detergents, cosmetics, and pharmaceuticals and as emulsifiers, lubricants, and plasticizers.

polyethylene glycol

A substance used with other ingredients to be used as a laxative. Brand names are Klean-prep and Movicol.
References in periodicals archive ?
Moviprep is marketed by Norgine through its own sales and marketing organisation and by Salix Pharmaceuticals (NASDAQ:SLXP) in the USA, by Medical Futures in Canada, by PharmaSwiss in central and eastern Europe and is under development with Ajinomoto (TYO:2802) in Japan.
Moviprep was developed by Norgine for bowel cleansing prior to colonscopy and its acceptance in the world's largest pharmaceutical market has delighted the company's chief executive office, Peter Stein.
We have every confidence that Moviprep can achieve great success both in the USA and Europe.'
Ralf Kiesslich, chief of endoscopy at the Johannes Gutenberg University Mainz (Germany), was more cautious, suggesting that the superiority of Moviprep should be confirmed in a second study.
But the results do suggest that Moviprep is at least as good and easier to use, Dr.
The study investigators randomized people who were undergoing screening colonoscopy at any of 12 German centers to treatment using either the Moviprep preparation or the Fleet regimen on a two-to-one basis.
The study was sponsored by Norgine, a German company that markets Moviprep in the United Kingdom.
The 242 people who used Moviprep and the 114 who received a Fleet prep were similar by gender and by average age and weight.
Experts rated results as A or B for 93% of participants in the Moviprep group (20% received an A and 73% got a B); individual gastroenterologists gave an A or B to 95%, Dr.
In the Fleet prep group, experts rated the results as A or B for 23%, and participating physicians gave these grades to 46% of patients, which were significantly lower rates than those in the Moviprep group.
In our study, however, overall excellent or good cleanliness was achieved in 60.7% of the patients (70.3% in patients in group 1, MoviPrep booster).
This past May, Novel received tentative approvals from the FDA for two Paragraph IV submissions for the generic versions of HalfLytely (Braintree Laboratories) and MoviPrep (Salix Pharmaceuticals).